Abstract
ADJUVANTS are widely used to increase antibody formation in experimental animals, for example, Freund's incomplete adjuvant, a water-in-oil emulsion containing the antigen, and Freund's complete adjuvant, which is the same but with killed tubercle bacilli. These adjuvants cannot be used in man because the mineral oil base is not degraded and persists at the injection site. Particularly with the complete adjuvant, unacceptable granulomas can be formed. There is real need for a safe and effective adjuvant for use in human immunisation programmes.
Similar content being viewed by others
Article PDF
References
Gregoriadis, G., and Buckland, R. A., Nature, 244, 170–172 (1973).
Gregoriadis, G., Swain, C. P., Wills, E. J., and Tavill, A. S., Lancet, i, 1313–1316 (1974).
Gregoriadis, G., and Allison, A. C., FEBS Lett., 44, 71–74 (1973).
Faulk, P. W., and Houba, V., J. Immun. Meth., 3, 87–98 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ALLISON, A., GREGORIADIS, G. Liposomes as immunological adjuvants. Nature 252, 252 (1974). https://doi.org/10.1038/252252a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/252252a0
This article is cited by
-
Liposomes for malaria management: the evolution from 1980 to 2020
Malaria Journal (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.